These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29156755)

  • 1.
    He L; Yang H; Liu F; Chen Y; Tang S; Ji W; Tang J; Liu Z; Sun Y; Hu S; Zhang Y; Liu X; Huang W; Ding X; Xia L
    Oncotarget; 2017 Oct; 8(49):85772-85782. PubMed ID: 29156755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal probiotics
    He L; Yang H; Tang J; Liu Z; Chen Y; Lu B; He H; Tang S; Sun Y; Liu F; Ding X; Zhang Y; Hu S; Xia L
    J Biol Eng; 2019; 13():58. PubMed ID: 31297149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor.
    You Y; Xue X; Li M; Qin X; Zhang C; Wang W; Giang C; Wu S; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    Cytotechnology; 2008 Feb; 56(2):97-104. PubMed ID: 19002847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGR enhanced the anti-angiogenic activity of tum-5.
    Meng J; Ma N; Yan Z; Han W; Zhang Y
    J Biochem; 2006 Aug; 140(2):299-304. PubMed ID: 16845126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice.
    Wei C; Xun AY; Wei XX; Yao J; Wang JY; Shi RY; Yang GH; Li YX; Xu ZL; Lai MG; Zhang R; Wang LS; Zeng WS
    Technol Cancer Res Treat; 2016 Jun; 15(3):498-508. PubMed ID: 25969440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vector-mediated Tum-5 expression in neovascular endothelial cells for treating hepatocellular carcinoma.
    Li C; Guan X; Sun B; Ma M; Wang P; Gai X
    Exp Ther Med; 2017 Apr; 13(4):1521-1525. PubMed ID: 28413503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin.
    Maeshima Y; Manfredi M; Reimer C; Holthaus KA; Hopfer H; Chandamuri BR; Kharbanda S; Kalluri R
    J Biol Chem; 2001 May; 276(18):15240-8. PubMed ID: 11278365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
    Li R; Helbig L; Fu J; Bian X; Herrmann J; Baumann M; Stewart AF; Müller R; Li A; Zips D; Zhang Y
    Res Microbiol; 2019 Mar; 170(2):74-79. PubMed ID: 30447257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
    Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
    Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Colonization and Therapy by
    Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
    Pasco S; Ramont L; Venteo L; Pluot M; Maquart FX; Monboisse JC
    Exp Cell Res; 2004 Dec; 301(2):251-65. PubMed ID: 15530861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.
    Zhang Y; Zhang Y; Xia L; Zhang X; Ding X; Yan F; Wu F
    Appl Environ Microbiol; 2012 Nov; 78(21):7603-10. PubMed ID: 22923405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
    Raghuvanshi R; Chaudhari A; Kumar GN
    Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu Q; Gai Y; Chen Y; Lan X; Jiang D
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.
    Montanaro J; Inic-Kanada A; Ladurner A; Stein E; Belij S; Bintner N; Schlacher S; Schuerer N; Mayr UB; Lubitz W; Leisch N; Barisani-Asenbauer T
    Drug Des Devel Ther; 2015; 9():3741-54. PubMed ID: 26229437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.